Financial Statements

DexCom, Inc. (DXCM)

$76.6

-1.07 (-1.38%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 2020 2019 2018 2017
Retained Earnings (Previous Year) -202-696-799-672-
Net Income 154494101-127-50
Stock Dividends 1-2--622
Dividend Paid -----
Retained Earnings -47-202-696-799-672

PPE Schedule

Year 2021 2020 2019 2018 2017
Gross PPE 609393183146-
Annual Depreciation 669415390105212
Capital Expenditure -389-199-180-67-66
Net PPE 889609393183146

Intangible and Goodwill Schedule

Year 2021 2020 2019 2018 2017
Intangible and Goodwill (Previous Year) -12191919
New Purchases -172-454-2,032-3,058-2,473
Intangible and Goodwill 1219191926

DexCom, Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes DexCom, Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.